Published in Biol Psychiatry on February 01, 1978
The neurophysiology of auditory hallucinations - a historical and contemporary review. Front Psychiatry (2011) 0.85
"Reality" of near-death-experience memories: evidence from a psychodynamic and electrophysiological integrated study. Front Hum Neurosci (2014) 0.78
The consensus sequence YGTGTTYY located downstream from the AATAAA signal is required for efficient formation of mRNA 3' termini. Nucleic Acids Res (1985) 7.18
Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J Exp Med (1988) 4.75
CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol (1996) 3.39
Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol (2001) 3.08
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med (1975) 2.57
Replication origins and a sequence involved in coordinate induction of the immediate-early gene family are conserved in an intergenic region of herpes simplex virus. Nucleic Acids Res (1984) 2.35
Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology (1998) 2.31
Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med (1976) 2.24
NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol (2000) 2.15
Determinants of disability after a work related musculetal injury. J Rheumatol (1998) 2.12
Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology (1990) 2.12
Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J Virol (1989) 2.05
Immediate-early mRNA-2 of herpes simplex viruses types 1 and 2 is unspliced: conserved sequences around the 5' and 3' termini correspond to transcription regulatory signals. Nucleic Acids Res (1983) 2.01
Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature (1999) 1.99
Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J Immunol (2000) 1.97
Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol (1998) 1.87
The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol (1995) 1.83
DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol (1995) 1.83
Videotape educational program for people with asthma. Can Med Assoc J (1979) 1.76
A modular system for the assay of transcription regulatory signals: the sequence TAATGARAT is required for herpes simplex virus immediate early gene activation. Nucleic Acids Res (1985) 1.75
DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J Virol (1997) 1.69
Prognosis in anorexia nervosa as influenced by clinical features, treatment and self-perception. Can Med Assoc J (1977) 1.52
A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci U S A (1999) 1.49
Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol (1998) 1.46
Sleep problems in children with attention-deficit/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication. J Am Acad Child Adolesc Psychiatry (1999) 1.46
Multiple tic syndrome (Giles de la Tourette's syndrome). J Nerv Ment Dis (1974) 1.45
Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis (1977) 1.45
Fibromyalgia and disability. Report of the Moss International Working Group on medico-legal aspects of chronic widespread musculoskeletal pain complaints and fibromyalgia. Scand J Rheumatol (1995) 1.44
A psychosomatic study of writer's cramp. Br J Psychiatry (1965) 1.44
Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med (2001) 1.44
Pain and mood patterns in patients with rheumatoid arthritis. A prospective study. Psychosom Med (1970) 1.41
The heterogeneity of anorexia nervosa. Bulimia as a distinct subgroup. Arch Gen Psychiatry (1980) 1.40
Vaccination to prevent persistent viral infection. J Virol (1993) 1.39
Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1998) 1.38
DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol (1998) 1.34
Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology (2000) 1.32
Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology (1997) 1.27
DNA immunization. Trends Microbiol (1996) 1.26
The junctions between the repetitive and the short unique sequences of the herpes simplex virus genome are determined by the polypeptide-coding regions of two spliced immediate-early mRNAs. J Gen Virol (1984) 1.24
Antigen-specific regulation of T cell-mediated cytokine production. Immunity (2000) 1.24
Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis (1985) 1.22
Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol (2001) 1.20
DNA immunization to prevent autoimmune diabetes. J Clin Invest (1999) 1.20
Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol (1985) (1994) 1.19
Physiological determinants of nocturnal arterial oxygenation in patients with obstructive sleep apnea. J Appl Physiol (1985) (1985) 1.18
An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci U S A (2000) 1.17
CTL escape viral variants. II. Biologic activity in vivo. Virology (1995) 1.15
Alpha sleep characteristics in fibromyalgia. Arthritis Rheum (2001) 1.14
A brief instrument for longitudinal monitoring of mood states. Psychiatry Res (1984) 1.13
Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J Virol (2000) 1.13
A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. Proc Natl Acad Sci U S A (1992) 1.12
Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol (1998) 1.11
Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization. J Virol (2000) 1.10
Personality, disease parameters and medication in rheumatoid arthritis. J Chronic Dis (1971) 1.10
Actigraphy and parental ratings of sleep in children with attention-deficit/hyperactivity disorder (ADHD). Sleep (2001) 1.07
Insomnia and health problems in Canadians. Sleep (2001) 1.07
Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities. J Virol (2001) 1.06
Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease. J Virol (2000) 1.04
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol (1999) 1.04
Clinical implications of dysregulated cytokine production. J Mol Med (Berl) (2000) 1.04
DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site. Vaccine (1997) 1.03
Viruses can silently prime for and trigger central nervous system autoimmune disease. J Neurovirol (2001) 1.03
Ribozymes which cleave arenavirus RNAs: identification of susceptible target sites and inhibition by target site secondary structure. J Virol (1992) 1.03
Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J Virol (1997) 1.03
The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol (1999) 1.02
Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther (2002) 1.01
The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan. Electroencephalogr Clin Neurophysiol (1980) 1.00
Biometeorology. Can Med Assoc J (1985) 0.99
Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients. J Rheumatol (2001) 0.99
Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein. J Virol (1989) 0.98
Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome. Can J Psychol (1991) 0.98
A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry (1978) 0.97
Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation. Chest (1988) 0.97
Adenosine: a mediator of interleukin-1beta-induced hippocampal synaptic inhibition. J Neurosci (1999) 0.95
CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting. J Virol (2001) 0.95
Infradian rhythms. A comparison of affective disorders and normal persons. Arch Gen Psychiatry (1985) 0.95
Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1993) 0.94
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry (1998) 0.94
Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine. Vaccine (2000) 0.94
The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum (1997) 0.93
The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med (1986) 0.93
Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol (1992) 0.92
Preferential coxsackievirus replication in proliferating/activated cells: implications for virus tropism, persistence, and pathogenesis. Curr Top Microbiol Immunol (2008) 0.92
Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta. J Immunol (1994) 0.92
DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity. FEMS Immunol Med Microbiol (1996) 0.92
Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain (1978) 0.92
A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. Infect Immun (1996) 0.91
Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. J Virol (1998) 0.91
Mechanics of the rib cage and diaphragm during sleep. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.91
The probability of recovery and return to work from work disability as a function of time. Qual Life Res (1994) 0.91
Body image disturbances in anorexia nervosa and obesity. Psychosom Med (1976) 0.90
Enhancing DNA immunization. Virology (2000) 0.90
Weather and infradian rhythms in self-reports of health, sleep and mood measures. J Psychosom Res (1982) 0.90
Hypothalamic-pituitary function in anorexia nervosa. Arch Gen Psychiatry (1975) 0.89
Periodicities in self-reports of health, sleep and mood variables. J Psychosom Res (1978) 0.89
Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. J Rheumatol (1997) 0.89